Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
2000 participants
OBSERVATIONAL
2012-12-31
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Medical records will be used to register demographic data, disease phenotype, the use of medication, flare-ups, surgery, hospitalizations, and mortality. Whole blood will be collected to central biobank with extraction of DNA ans seroum. The Montreal classification of Crohn's disease and the Crohn's disease activity index (CDAI) will be used to describe disease location, behavior and severity. F/U data will be analyzed using Kaplan-Meier analysis with log rank test and Cox regression analysis. An electronic database will be established in use of processing data.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Crohn's disease
Korean patients diagnosed with Crohn's disease
Observation study
No intervention was administered to the participants specifically for the purpose this study. Participant could be on any drug therapy.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Observation study
No intervention was administered to the participants specifically for the purpose this study. Participant could be on any drug therapy.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Informed consent
* Patients who had a definitive diagnosis of Crohn's disease (documented by the standard clinical, radiographic, endoscopic, and histopathologic criteria)
* be capable of understanding the study and replying to the questionnaires
Exclusion Criteria
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Asan Medical Center
OTHER
Hanyang University
OTHER
Seoul National University
OTHER
Severance Hospital
OTHER
Samsung Medical Center
OTHER
Chung-Ang University Hosptial, Chung-Ang University College of Medicine
OTHER
Kyung Hee University Hospital at Gangdong
OTHER
Kangbuk Samsung Hospital
OTHER
Konyang University Hospital
OTHER
Korea University Anam Hospital
OTHER
Korea University
OTHER
Eulji General Hospital
OTHER
Eulji University
OTHER
SMG-SNU Boramae Medical Center
OTHER
Pusan National University Hospital
OTHER
Inje University
OTHER
Soonchunhyang University Hospital
OTHER
Songdo hospital
UNKNOWN
Yeungnam University Hospital
OTHER
Wonkwang University
OTHER
Wonju Severance Christian Hospital
OTHER
Ewha Womans University
OTHER
Chonnam National University Hospital
OTHER
Jeju National University Hospital
OTHER
Chuncheon Sacred Heart Hospital
OTHER
Hangang Sacred Heart Hospital
OTHER
Dongtan Sacred Heart Hospital
OTHER
Chungbuk National University Hospital
OTHER
The Catholic University of Korea
OTHER
Kyunghee University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chang Kyun Lee
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joo Sung Kim, MD, PhD
Role: STUDY_CHAIR
Seoul National University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hanyang University Guri Hospital
Guri-si, , South Korea
Kyunghee University Medical Center
Seoul, , South Korea
Asan Medical Center
Seoul, , South Korea
Chung-Ang University
Seoul, , South Korea
Inje University
Seoul, , South Korea
Samsung Medical Center
Seoul, , South Korea
Seoul National University SMG-SNU Boramae Medical Center
Seoul, , South Korea
The Catholic University of Korea St. Vincent Hospital
Seoul, , South Korea
Yonsei University; Severance Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ye BD, Yang SK, Cho YK, Park SH, Yang DH, Yoon SM, Kim KJ, Byeon JS, Myung SJ, Yu CS, Kim JH. Clinical features and long-term prognosis of Crohn's disease in Korea. Scand J Gastroenterol. 2010 Oct;45(10):1178-85. doi: 10.3109/00365521.2010.497936.
Kim ES, Kim WH. Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics. Gut Liver. 2010 Mar;4(1):1-14. doi: 10.5009/gnl.2010.4.1.1. Epub 2010 Mar 25.
Ye BD, Jang BI, Jeen YT, Lee KM, Kim JS, Yang SK; IBD Study Group of the Korean Association of the Study of Intestinal Diseases. [Diagnostic guideline of Crohn's disease]. Korean J Gastroenterol. 2009 Mar;53(3):161-76. Korean.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KCDC 2011-088
Identifier Type: -
Identifier Source: org_study_id